Octapharma USA announced the Journal of the American Medical Association (JAMA) has published results from a Phase III clinical trial, which observed non-activated four factor prothrombin complex ...
No other corporate actions details are available.
When Tim Noonan's shoulder tore in 2014, stem cell therapy eased his extreme pain - 10 years later, he returns for more of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果